Phantom Neuro
PrivateLast Round
Series B
Oct 20, 2026
Est. Valuation
$53.9M
Total Funding Raised
$28.56M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Phantom Neuro operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Grant round in September 2025.
Phantom Neuro is a neurotechnology company developing a minimally invasive neural interface that enables intuitive control of prosthetic limbs and robotic exoskeletons.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phantom Neuro Comparables
Compare Phantom Neuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blue Arbor Technologies, Inc. | 81% | |
| Esper Bionics | 81% | |
| Coapt | 81% |
For institutional investors. Book with your work email.
Phantom Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 20, 2026 | ||||
| Grant | Sep 10, 2025 | ||||
| Series A | Apr 15, 2025 | ||||
| Seed | Sep 12, 2022 | ||||
| Seed | Mar 25, 2022 |
For institutional investors. Book with your work email.
Phantom Neuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Risk and Return | Series A |
| Brown Advisory | Series A |
| Time BioVentures | Series A, Seed |
| Gaingels | Series A |
| Risk and Return | Series A |
| Capital Factory | Seed |
| MainSheet Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2026
$30M round completed.
- Aug 22, 2026
Monthly visitors increased 33% to 4.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 29, 2026
Phantom Neuro is developing Phantom X, a minimally invasive muscle-machine interface designed to interpret electrical signals generated when a person intends to move and being studied to enable more intuitive control of prosthetic limbs and other robotic systems.
- partners_withSep 29, 2026
Phantom Neuro partnered with Amputee Coalition through its Partnership Program to support people with limb loss or limb difference in District of Columbia on Sep 29th '26.
For institutional investors. Book with your work email.
Phantom Neuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phantom Neuro's valuation, stock price, and market status.
Is Phantom Neuro a public or private company?
Phantom Neuro is a private company.
What is the current stock price of Phantom Neuro?
Phantom Neuro is a private company, so its shares have no public market price. Caplight tracks Phantom Neuro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phantom Neuro worth (valuation)?
Phantom Neuro's valuation is estimated at $53.9M based on funding round data.
Can I buy Phantom Neuro stock?
Phantom Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phantom Neuro's last funding round?
Phantom Neuro's most recent funding round was Series B on October 20, 2026.
Who are the main investors in Phantom Neuro?
Key investors in Phantom Neuro include Time BioVentures, LionBird.
Will Phantom Neuro IPO soon?
No public IPO plans have been announced for Phantom Neuro.
How can I track Phantom Neuro secondary market activity?
Caplight tracks bids, offers, and trades in Phantom Neuro's shares on secondary markets.